Peptides · Clinician-Reviewed Protocols | IVUSE+ - IVUSE Plus
Every compound, fully protocoled. Mechanism, dose, route, cadence, cycle.
Peptides are short chains of amino acids the body already uses as signaling molecules. Where GLP-1 medications act on a single hunger and metabolism axis, the compounds in this catalog span growth hormone release, tissue repair, copper-bound skin regeneration, and central nervous system arousal. Clinician-reviewed, not supplement-aisle.
Pulsatile GH release through the GHRH receptor. The only peptide in this catalog with published trial data on visceral adipose reduction. FDA studied it for lipodystrophy. The recomp crowd found it anyway.
GH secretagogue without the cortisol bleed or prolactin creep that makes other GHRPs a headache to dose long-term. Cleanest release profile in the class. The reason most serious stacks start here.
The lipolytic fragment of growth hormone, cut from the chain and run solo. Fat oxidation without the anabolic overhead. Quietly moved from Australian obesity trials in the early 2000s to every serious aesthetic practice that does its own reading.
Copper-chelated tripeptide. Upregulates collagen III, activates follicle stem cells, and accelerates wound remodeling. Subcutaneous delivery puts it in the dermal compartment at concentrations no topical formulation gets close to.
Mitochondria-derived. Encoded in the 12S rRNA gene, not the nuclear genome. Activates AMPK, improves insulin sensitivity, and runs on a signaling pathway older than the organism using it. The molecule your cells already write.
Active fragment of Thymosin Beta-4. Regulates actin polymerization, promotes angiogenesis, reduces inflammation at the injury site. The recovery compound that circulates through every serious training camp and zero official interviews.
Bremelanotide. MC4R agonist. Central nervous system arousal, not peripheral vasodilation. It works on desire, not blood flow. The distinction matters more than most providers bother to explain.
GHRH. Where Ipamorelin sets the frequency, CJC sets the amplitude. Paired together, each nightly pulse carries more payload than either delivers alone.
Isolated from gastric juice. Signals repair across gut mucosa, tendons, and ligaments through pathways researchers still argue about in the literature. No FDA approval. No shortage of published data. No shortage of people who swear by it.
Synthetic ACTH(4-10) analog. Upregulates BDNF in the prefrontal cortex. Sustained executive function, clean onset, clean offset. Developed in Russia, adopted by the subset of cognitive optimizers who read primary sources instead of Reddit threads.
Tuftsin-derived anxiolytic peptide. GABAergic modulation without sedation, without tolerance buildup, without the cognitive tax every benzo charges on the way out. Works in minutes. The composure nobody in the room can trace.
Synthetic GHRH(1-29), the active fragment of growth hormone-releasing hormone. Shorter half-life than CJC-1295 means closer-to-natural pulsatile release. Formerly FDA-approved as Geref. The classical GHRH, before the field went long-acting.
Four repair peptides in one vial. GHK-Cu rebuilds collagen, BPC-157 patches connective tissue, TB-500 mobilizes healing cells, and KPV shuts down the inflammation that stalls all of it. One injection, four lanes of recovery.
Peptides are short chains of amino acids the body already uses as signaling molecules. Each compound in this catalog targets a specific pathway: growth hormone release, tissue repair, collagen signaling, central nervous system arousal. Think of them as precise instructions rather than broad drug effects.
Yes. Every order is reviewed by a licensed clinician before it ships. The intake is short, the review is real, and not every candidate qualifies. Peptide access is contingent on medical eligibility, not cart contents.
GLP-1 medications act on a single hunger and metabolism axis. The compounds in this catalog span a wider range: visceral fat mobilization, growth hormone release, tissue repair, cognitive support, libido. They are not a replacement for GLP-1s, they are the molecules GLP-1 doesn't address.
Safety profiles vary by compound and depend on dose, route, and individual eligibility. That's why clinician review is not optional here. Some of the peptides we carry are FDA-studied. Others are research-grade with decades of published data but no formal FDA approval. The intake determines fit.
Overnight shipping, cold chain where required, sharps included. Pricing is a flat 30-day supply, paid once. No subscription. No auto-renewal. You finish a cycle, you decide what comes next.
